Help with healthcare costs for lipodystrophy
This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Check your eligibility with our quick and easy tools below. If this fund is open, apply today for an instant approval decision and use your grant funding right away. Learn how TotalAssist helps you.
Eligibility criteria
To be eligible for this fund, you must:
- Have a confirmed diagnosis and are in treatment for lipodystrophy, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months. This includes active surveillance of a condition
- Have health insurance that covers your qualifying expenses
- Have an income at or less than 500% of the Federal Poverty Level, adjusted for your regional Cost of Living Index (COLI). What is this?
- Be a legal resident and receive treatment in the U.S. or a U.S. territory
- Be prescribed a medication or product listed in the approved medications, listed below
Quick eligibility checker
- Treatment
- Insurance
- Income
Approved medications
Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines.
- 30 (Insulin Isophane Nph And Insulin Human)
- Accupril (Quinapril)
- Actos (Pioglitazone)
- Afrezza (Insulin Human, Inhaled)
- Aldactone (Spironolactone)
- Altace (Ramipril)
- Apidra (Insulin Glulisine)
- Atacand (Candesartan)
- Avapro (Irbesartan)
- Basaglar (Insulin Glargine)
- Benicar (Olmesartan)
- Bumex (Bumetanide)
- Capoten (Captopril)
- Cardizem (Diltiazem)
- Coreg (Carvedilol)
- Coversyl (Perindopril)
- Cozaar (Losartan)
- Crestor (Rosuvastatin)
- Diovan (Valsartan)
- Edarbi (Azilsartan)
- Egrifta (Tesamorelin)
- Farxiga (Dapagliflozin)
- Fiasp (Insulin Aspart)
- Glucophage (Metformin)
- Humalog U-200 (Insulin Lispro)
- Humulin N (Insulin Human Nph)
- Humulin R (Insulin Human Regular)
- Humulin R U-500 (Insulin Human Regular)
- Imdur (Isosorbide Mononitrate)
- Invokana (Canagliflozin)
- Isordil (Isosorbide Dinitrate)
- Janumet (Sitagliptin And Metformin)
- Januvia (Sitagliptin)
- Jardiance (Empagliflozin)
- Kengreal (Cangrelor)
- Lantus (Insulin Glargine)
- Lasix (Furosemide)
- Leqvio (Inclisiran)
- Leschol (Fluvastatin)
- Levemir (Insulin Detemir)
- Lipitor (Atorvastatin)
- Livalo (Pitavastatin)
- Lodoco (Colchicine)
- Lopid (Gemfibrozil)
- Lopressor (Metoprolol)
- Lotensin (Benazapril)
- Lovaza (Omega-3-Acid Ethyl Esters)
- Mevacor (Lovastatin)
- Microzide (Hydrochlorothiazide)
- Monopril (Fosinopril)
- Mounjaro (Tirzepatide)
- Myalept (Metreleptin)
- Nexletol (Bempedoic Acid)
- Nexlizet (Bempedoic Acid And Ezetimibe)
- Nitrostat (Nitroglycerin)
- Norvasc (Amlodipine)
- Novolin (Insulin Human)
- Novolin (Insulin Isophane Nph)
- Novolin (Insulin Isophane Nph And Insulin Human)
- Novolog (Insulin Aspart)
- ONGLYZA (Saxagliptin)
- Ozempic (Semaglutide)
- Praluent (Alirocumab)
- Pravachol (Pravastatin)
- Precose (Acarbose)
- Procardia XL (Nifedipine)
- Ranexa (Ranolazine)
- Repatha (Evolocumab)
- Rybelsus (Semaglutide)
- Saxenda (Liraglutide)
- Symlin (Pramlintide)
- Tenormin (Atenolol)
- Toujeo (Insulin Glargine)
- Tradjenta (Linagliptin)
- Tresiba (Insulin Degludec)
- Tricor (Fenofibrate)
- Trulicity (Dulaglutide)
- Vascepa (Icosapent Ethyl)
- Vasotec (Enalapril)
- Victoza (Liraglutide)
- Wegovy (Semaglutide)
- Zestril (Lisinopril)
- Zetia (Ezetimibe)
- Zocor (Simvastatin)
About the disease
Lipodystrophy is a group of disorders of adipose tissue (fat) characterized by selective loss of fat from various parts of the body. There are several types of lipodystrophies, and the degree of fat loss may range from very small, depressed areas to a near-complete absence of adipose tissue. These disorders can be either inherited (familial or genetic) lipodystrophies or secondary to various illnesses or drugs (acquired lipodystrophies).
Diagnosis codes
E88.10, E88.11, E88.12, E88.13, E88.14, E88.19
How to apply
-
If your fund is open, apply online 24/7, or call 866-512-3861, Monday – Friday, 8:30am – 5:30pm ET.
-
Answer pre-screening questions to confirm eligibility. Have your income, medication, diagnosis, and insurance information ready.
-
Complete the application and get an instant approval decision. You can begin using your grant right away.
Application guides
Questions?
Search help articles
Find answers to your questions about applying, claims, grant use, and your portal account.
Search help
How does it work?
You can use your TotalAssist grant award to help pay for out-of-pocket healthcare expenses.
Learn more
Need help applying?
Call us at 866-512-3861 to apply by phone, Monday through Friday, 8:30am - 5:30pm ET.
Contact usRelated organizations
Connect with other organizations and resources for support.
Explore resources beyond TotalAssist
Patient Advocate Foundation knows that patients may need support, information, and resources beyond TotalAssist. This can include services like case management, help with living expenses, and much more. Search our National Financial Resources Directory, find community specific resources, and explore our patient education library.
Find resources